FDA clears first melanoma drug to extend survival
Friday, March 25, 2011 - 12:30
in Health & Medicine
(AP) -- The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with melanoma.